McDonaldJA, TehranifarP, FlomJD, et al.Hair product use, age at menarcheand mammographic breast density in multiethnic urban women. Environ Health2018;17(1):1; doi: 10.1186/s12940-017-0345-y
3.
WiseLA, WangTR, NcubeCN, et al.Use of chemical hair straighteners and fecundability in a North American preconception cohort. Am J Epidemiol2023;192(7):1066–1080; doi: 10.1093/aje/kwad079
4.
WiseLA, PalmerJR, ReichD, et al.Hair relaxer use and risk of uterine leiomyomata in African-American women. Am J Epidemiol2012;175(5):432–440; doi: 10.1093/aje/kwr351
5.
OgunsinaK, O’BrienKM, WhiteAJ, et al.Hair straightener use in relation to prevalent and incident fibroids in the Sister Study with a focus on Black women. Environ Health Perspect2025;133(1):17004; doi: 10.1289/EHP14493
6.
PierceJS, AbelmannA, SpicerLJ, et al.Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg2011;8(11):686–699; doi: 10.1080/15459624.2011.626259
7.
BertrandKA, DelpL, CooganPF, et al.Hair relaxer use and risk of uterine cancer in the Black Women’s Health Study. Environ Res2023;239(Pt 1):117228; doi: 10.1016/j.envres.2023.117228
8.
MunroMG, FIGO Committee on Menstrual Disorders. Abnormal uterine bleeding: A well-travelled path to iron deficiency and anemia. Int J Gynaecol Obstet2020;150(3):275–277; doi: 10.1002/ijgo.13180
9.
WhiteAJ, SandlerDP, GastonSA, et al.Use of hair products in relation to ovarian cancer risk. Carcinogenesis2021;42(9):1189–1195; doi: 10.1093/carcin/bgab056
10.
BrintonLA, FigueroaJD, AnsongD, et al.Skin lighteners and hair relaxers as risk factors for breast cancer: Results from the Ghana breast health study. Carcinogenesis2018;39(4):571–579; doi: 10.1093/carcin/bgy002
11.
EberleCE, SandlerDP, TaylorKW, et al.Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women. Int J Cancer2020;147(2):383–391; doi: 10.1002/ijc.32738
12.
WhiteAJ, GregoireAM, TaylorKW, et al.Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk. Int J Cancer2021;148(9):2255–2263; doi: 10.1002/ijc.33413
13.
FarooqH, MhatreP, AggarwalR, et al.A systematic review of association between use of hair products and benign and malignant gynecological conditions. Eur J Obstet Gynecol Reprod Biol2024;295:160–171; doi: 10.1016/j.ejogrb.2024.02.012
MunroMG, CritchleyHOD, FraserIS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet2018;143(3):393–408; doi: 10.1002/ijgo.12666
16.
KleinJR, LittIF. Epidemiology of adolescent dysmenorrhea. Pediatrics1981;68(5):661–664.
17.
ArmourM, ParryK, ManoharN, et al.The prevalence and academic impact of dysmenorrhea in 21,573 young women: A systematic review and meta-analysis. J Womens Health (Larchmt)2019;28(8):1161–1171; doi: 10.1089/jwh.2018.7615
18.
YilmazB, TerekeciH, SandalS, et al.Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord2020;21(1):127–147; doi: 10.1007/s11154-019-09521-z
19.
AhnC, JeungEB. Endocrine-Disrupting chemicals and disease endpoints. Int J Mol Sci2023;24(6):5342; doi: 10.3390/ijms24065342
20.
GellerRJ, SchildrothS, NoelNL, et al.Use of chemical hair straighteners and menstrual disturbances. J Women’s Health2026;35(7):641–653; doi: 10.1177/15409996261431046
21.
Miranda-VilelaAL, BotelhoAJ, MuehlmannLA. An overview of chemical straightening of human hair: Technical aspects, potential risks to hair fibre and health and legal issues. Int J Cosmet Sci2014;36(1):2–11; doi: 10.1111/ics.12093
HelmJS, NishiokaM, BrodyJG, et al.Measurement of endocrine disrupting and asthma-associated chemicals in hair products used by Black women. Environ Res2018;165:448–458; doi: 10.1016/j.envres.2018.03.030
24.
OdukuduFB, AyenimoJG, AdekunleAS, et al.Safety evaluation of heavy metals exposure from consumer products. Int J Consumer Studies2014;38(1):25–34; doi: 10.1111/ijcs.12061
25.
RosenbergL, BoggsDA, Adams-CampbellLL, et al.Hair relaxers not associated with breast cancer risk: Evidence from the Black Women’s Health Study. Cancer Epidemiol Biomarkers Prev2007;16(5):1035–1037; doi: 10.1158/1055-9965.EPI-06-0946
26.
GastonSA, James-ToddT, HarmonQ, et al.Chemical/straightening and other hair product usage during childhood, adolescence, and adulthood among African-American women: Potential implications for health. J Expo Sci Environ Epidemiol2020;30(1):86–96; doi: 10.1038/s41370-019-0186-6
27.
EdwardsL, AhmedL, MartinezL, et al.Beauty Inside Out: Examining beauty product use among diverse women and femme-identifying individuals in Northern Manhattan and South Bronx through an environmental justice framework. Environ Justice2023;16(6):449–460; doi: 10.1089/env.2022.0053
28.
LlanosAAM, RabkinA, BanderaEV, et al.Hair product use and breast cancer risk among African American and White women. Carcinogenesis2017;38(9):883–892; doi: 10.1093/carcin/bgx060
29.
ZotaAR, ShamasunderB. The environmental injustice of beauty: Framing chemical exposures from beauty products as a health disparities concern. Am J Obstet Gynecol2017;217(4):418.e1–418.e6; doi: 10.1016/j.ajog.2017.07.020
30.
James-ToddT, SenieR, TerryMB. Racial/ethnic differences in hormonally-active hair product use: A plausible risk factor for health disparities. J Immigr Minor Health2012;14(3):506–511; doi: 10.1007/s10903-011-9482-5
ErnstoffAS, FantkeP, CsiszarSA, et al.Multi-pathway exposure modeling of chemicals in cosmetics with application to shampoo. Environ Int2016;92–93:87–96; doi: 10.1016/j.envint.2016.03.014
33.
BormannJL, MaibachHI. Effects of anatomical location on in vivo percutaneous penetration in man. Cutan Ocul Toxicol2020;39(3):213–222; doi: 10.1080/15569527.2020.1787434
